Preparation and physical properties of conjugates of oligodeoxynucleotides with poly(delta)ornithine peptides.

Oligodeoxynucleotides (12-mers) having either a 3' aminolinker or both 3' and 5' aminolinker groups were synthesized and then reacted with N-iodoacetoxysuccinimide. Separately, a series of peptides, consisting of cysteine carboxyamide and a varying number of residues of ornithine coupled through their side-chain amino groups, was prepared, leaving on the final Fmoc protecting group. Reaction of each Fmoc-peptide with an activated oligodeoxynucleotide yielded the desired conjugates, which were purified by an Fmoc-on/Fmoc-off two-step reversed-phase HPLC procedure. On hybridization with a complementary unmodified 12-mer oligodeoxynucleotide, it was found that there is a gradual increase in melting temperature with the number of ornithine residues, whereas the appended peptide did not perturb the B form of the duplex.

[1]  K. Breslauer,et al.  Oligonucleotide-poly-L-ornithine conjugates: binding to complementary DNA and RNA. , 1993, Antisense research and development.

[2]  I. D'Agnano,et al.  Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K Zatloukal,et al.  Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Tinsley,et al.  In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides. , 1992, Nucleic acids research.

[5]  S. Stein,et al.  Preparation of oligonucleotide-peptide conjugates. , 1991, Bioconjugate chemistry.

[6]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Haralambidis,et al.  The synthesis of polyamide-oligonucleotide conjugate molecules. , 1990, Nucleic acids research.

[9]  P. Iversen,et al.  Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotides. , 1989, The Journal of general virology.

[10]  B. Lebleu,et al.  Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides. , 1988, Gene.

[11]  S. Stein,et al.  Gas-phase hydrolysis of proteins and peptides. , 1987, Analytical biochemistry.

[12]  M Lemaitre,et al.  Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Bisbal,et al.  Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells. , 1986, Biochemistry.

[14]  A. Hampton,et al.  Evidence for species-specific substrate-site-directed inactivation of rabbit adenylate kinase by N6-(6-iodoacetamido-n-hexyl)adenosine 5'-triphosphate. , 1976, Journal of medicinal chemistry.

[15]  C. Wu,et al.  N-(1-pyrene)maleimide: a fluorescent cross-linking reagent. , 1976, Biochemistry.

[16]  P. Schell.  Uptake of polynucleotides by mammalian cells. XIV. Stimulation of the uptake of polynucleotides by poly(L-lysine). , 1974, Biochimica et biophysica acta.